Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats.
Dakin CL, Small CJ, Park AJ, Seth A, Ghatei MA, Bloom SR. Dakin CL, et al. Among authors: ghatei ma. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1173-7. doi: 10.1152/ajpendo.00233.2002. Epub 2002 Jul 30. Am J Physiol Endocrinol Metab. 2002. PMID: 12388165 Free article.
We reported that intracerebroventricular (ICV) and intranuclear administration of OXM caused an inhibition of food intake in rats (Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, and Bloom SR. Endocrinology 142: 4244-4250, 2001). In this study, …
We reported that intracerebroventricular (ICV) and intranuclear administration of OXM caused an inhibition of food intake in rats (Dakin CL, …
Inhibition of food intake in obese subjects by peptide YY3-36.
Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Batterham RL, et al. Among authors: ghatei ma. N Engl J Med. 2003 Sep 4;349(10):941-8. doi: 10.1056/NEJMoa030204. N Engl J Med. 2003. PMID: 12954742 Free article. Clinical Trial.
Oxyntomodulin suppresses appetite and reduces food intake in humans.
Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, Bloom SR. Cohen MA, et al. Among authors: ghatei ma. J Clin Endocrinol Metab. 2003 Oct;88(10):4696-701. doi: 10.1210/jc.2003-030421. J Clin Endocrinol Metab. 2003. PMID: 14557443 Clinical Trial.
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, Frost GS, Ghatei MA, Bloom SR. Neary NM, et al. Among authors: ghatei ma. Endocrinology. 2005 Dec;146(12):5120-7. doi: 10.1210/en.2005-0237. Epub 2005 Sep 8. Endocrinology. 2005. PMID: 16150917 Clinical Trial.
Low-dose pancreatic polypeptide inhibits food intake in man.
Jesudason DR, Monteiro MP, McGowan BM, Neary NM, Park AJ, Philippou E, Small CJ, Frost GS, Ghatei MA, Bloom SR. Jesudason DR, et al. Among authors: ghatei ma. Br J Nutr. 2007 Mar;97(3):426-9. doi: 10.1017/S0007114507336799. Br J Nutr. 2007. PMID: 17313701 Clinical Trial.
Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake.
Gardiner JV, Bataveljic A, Patel NA, Bewick GA, Roy D, Campbell D, Greenwood HC, Murphy KG, Hameed S, Jethwa PH, Ebling FJ, Vickers SP, Cheetham S, Ghatei MA, Bloom SR, Dhillo WS. Gardiner JV, et al. Among authors: ghatei ma. Diabetes. 2010 Feb;59(2):397-406. doi: 10.2337/db09-1198. Epub 2009 Nov 23. Diabetes. 2010. PMID: 19933997 Free PMC article.
522 results